Sumitomo Mitsui Trust Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
FAM
CIP
TCM
O
Sumitomo Mitsui Trust Group's ATRC Position: Q3 2020 in Review
Sumitomo Mitsui Trust Group sold out of AtriCure (ATRC) in Q3 2020, closing a stake of 5,812 shares — an estimated $261K sold.
Sumitomo Mitsui Trust Group first reported a position in ATRC in Q4 2018 and held it in 3 quarters. The position peaked at $703K in Q4 2018. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2020.
- Sumitomo Mitsui Trust Group reported no remaining AtriCure position as of Q3 2020 after selling out during the quarter.
- Sumitomo Mitsui Trust Group sold 5,812 AtriCure shares in Q3 2020, an estimated $261K.
- Sumitomo Mitsui Trust Group first reported a position in AtriCure in Q4 2018 and held it in 3 quarters.
- Sumitomo Mitsui Trust Group's AtriCure position peaked at $703K in Q4 2018.
- 183 funds tracked by Wall St. Rank held AtriCure as of Q3 2020.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2020, filed 30 Oct 2020.